CliffBio
small molecule

NOVANTRONE

MITOXANTRONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyEMD Serono →See this company's full patent-cliff portfolio

Drug detail

Brand nameNOVANTRONE
Active ingredientMITOXANTRONE HYDROCHLORIDE
StrengthEQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1987
Marketing statusDISCN

More from EMD Serono

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.